Strumento inattivo

Azioni Cadence Pharmaceuticals, Inc.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results	28/02/14
Cadence Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.	12/02/14
Cadence Pharmaceuticals, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders	11/02/14
Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance	13/01/14

Dirigenti	Titolo	Età	Da
Bryan Reasons PSD	President	56	-
Diane K. Sheehan HRO	Human Resources Officer	54	01/05/06

Amministratori	Titolo	Età	Da
Bryan Reasons PSD	President	56	-
Marvin R. Haselhorst BRD	Director/Board Member	-	19/03/14

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-3,11%	89,49 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+2,50%	40,67 Mrd
BIOGEN INC.	-12,01%	33,15 Mrd
UCB	+62,74%	26,45 Mrd
BIOMARIN PHARMACEUTICAL INC.	-19,79%	14,69 Mrd
INCYTE CORPORATION	-8,58%	12,89 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12,34%	11,54 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,92%	11,34 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+4,27%	8,84 Mrd